Figure 3
The non DC in lin-HLA DR+ cell population is increased in individuals with different types of pancreatic cancers and chronic pancreatitis. Percentage of non DC (lin-HLA DR+ CD11c-CD123-) within the lin-HLA DR+ cell population in healthy age match controls and pancreatic duct adenocarcinoma (PDAC), none resectable pancreatic tumor (NRPT), billary duct adenocarcinoma (BDAC), ampullary carcinoma (AC), endocrine carcinoma (EC), and chronic pancreatitis (CP) prior surgery (A) and after surgery (B). The proportion of non DC was estimated as the mean percentage of the total amount of lin-HLA-DR+ cells. Statistically significant differences between individuals with pancreatic disease and healthy controls are indicated as; * = p < 0.05, ** = p < 0.005, *** = p < 0.001.